What is the treatment algorithm for hyponatremia (low sodium levels)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hyponatremia Treatment Algorithm

Initial Assessment and Classification

Assess symptom severity immediately, as this determines the urgency and aggressiveness of treatment. 1

Symptom Severity Categories

  • Severe symptoms (seizures, coma, altered mental status, respiratory distress): Medical emergency requiring immediate hypertonic saline 1, 2
  • Mild symptoms (nausea, vomiting, headache, weakness): Less urgent, allows time for diagnostic workup 1, 3
  • Asymptomatic: Treatment based on severity of sodium level and underlying cause 1, 3

Sodium Level Classification

  • Mild: 130-135 mEq/L 3
  • Moderate: 125-129 mEq/L (or 120-125 mEq/L per some guidelines) 1, 3
  • Severe: <125 mEq/L (or <120 mEq/L) 1, 3

Volume Status Assessment

Determine if the patient is hypovolemic, euvolemic, or hypervolemic through physical examination 1:

  • Hypovolemic signs: Orthostatic hypotension, dry mucous membranes, decreased skin turgor, flat neck veins 1
  • Euvolemic: No edema, normal blood pressure, normal skin turgor, moist mucous membranes 1
  • Hypervolemic signs: Peripheral edema, ascites, jugular venous distention 1

Essential Laboratory Workup

  • Serum osmolality, urine osmolality, urine sodium, urine electrolytes 1
  • Serum uric acid (<4 mg/dL suggests SIADH with 73-100% positive predictive value) 1
  • Thyroid function (TSH) and cortisol to rule out hypothyroidism and adrenal insufficiency 1
  • Urine sodium <30 mmol/L predicts 71-100% response to saline in hypovolemic hyponatremia 1

Treatment Based on Symptom Severity

SEVERE SYMPTOMATIC HYPONATREMIA (Seizures, Coma, Altered Mental Status)

Administer 3% hypertonic saline immediately—this is a medical emergency. 1, 2, 3

Dosing Protocol

  • Give 100 mL bolus of 3% saline over 10 minutes 1
  • Can repeat up to 3 times at 10-minute intervals until symptoms improve 1
  • Target: Increase sodium by 6 mEq/L over first 6 hours or until symptoms resolve 1, 2

Critical Safety Limits

  • Never exceed 8 mEq/L correction in 24 hours 1, 2, 3
  • Monitor serum sodium every 2 hours during initial correction 1
  • Transfer to ICU for close monitoring 2

High-Risk Patients (Require Even Slower Correction at 4-6 mEq/L per day)

  • Advanced liver disease, cirrhosis 1
  • Alcoholism or malnutrition 1
  • Prior encephalopathy 1
  • Severe hyponatremia <120 mEq/L 1

MILD SYMPTOMS OR ASYMPTOMATIC HYPONATREMIA

Treatment is determined by volume status and underlying etiology 1, 3:


Treatment Based on Volume Status

HYPOVOLEMIC HYPONATREMIA

Administer isotonic (0.9%) normal saline for volume repletion. 1, 3

  • Discontinue diuretics immediately 1
  • Urine sodium <30 mmol/L confirms hypovolemic state and predicts good response to saline 1
  • Correct at rate not exceeding 8 mEq/L in 24 hours 1

Common causes: Diuretics, GI losses (vomiting, diarrhea), burns, dehydration 1


EUVOLEMIC HYPONATREMIA (SIADH)

Fluid restriction to 1 L/day is the cornerstone of treatment. 1, 2, 3

First-Line Treatment

  • Restrict fluids to 1000 mL/day 1, 2
  • Monitor sodium every 24-48 hours initially 2

Second-Line Options (if fluid restriction fails)

  • Oral sodium chloride tablets: 100 mEq three times daily 4, 2
  • High protein diet to augment solute intake 4
  • Urea 0.25-0.50 g/kg/day (highly effective, induces osmotic diuresis) 2
  • Demeclocycline (induces nephrogenic diabetes insipidus) 2

Third-Line: Vaptans (Vasopressin Receptor Antagonists)

  • Tolvaptan starting dose: 15 mg once daily 1, 5
  • Can titrate to 30 mg, then 60 mg daily based on response 5
  • Avoid fluid restriction in first 24 hours when starting tolvaptan to prevent overly rapid correction 5
  • Monitor closely—risk of overcorrection 1
  • Caution in cirrhosis: 10% risk of GI bleeding vs 2% with placebo 1

SIADH diagnostic criteria: Euvolemic state, urine sodium >20-40 mEq/L, urine osmolality >300-500 mOsm/kg, normal thyroid/adrenal function 1, 2


HYPERVOLEMIC HYPONATREMIA (Heart Failure, Cirrhosis)

Fluid restriction to 1-1.5 L/day for sodium <125 mEq/L. 1, 3

Management Steps

  • Implement fluid restriction to 1000-1500 mL/day 1
  • Discontinue diuretics temporarily if sodium <125 mEq/L 1
  • For cirrhosis: Consider albumin infusion alongside fluid restriction 1
  • Avoid hypertonic saline unless life-threatening symptoms present—it worsens ascites and edema 1

Pharmacological Options

  • Tolvaptan may be considered for persistent severe hyponatremia despite fluid restriction 1, 5
  • Use with extreme caution in cirrhosis due to bleeding risk 1

Key principle: In cirrhosis, sodium restriction (not fluid restriction) causes weight loss, as fluid follows sodium 1


Special Populations and Considerations

NEUROSURGICAL PATIENTS: Cerebral Salt Wasting (CSW) vs SIADH

Critical distinction: CSW requires volume and sodium replacement, NOT fluid restriction 1

CSW Diagnostic Features

  • True hypovolemia with CVP <6 cm H₂O 1
  • Urine sodium >20 mEq/L despite volume depletion 1
  • Evidence of extracellular volume depletion (hypotension, tachycardia, dry mucous membranes) 1

CSW Treatment

  • Volume repletion with normal saline or hypertonic saline 1
  • For severe symptoms: 3% hypertonic saline + fludrocortisone 0.1-0.2 mg daily in ICU 1
  • Hydrocortisone may prevent natriuresis in subarachnoid hemorrhage patients 1
  • Never use fluid restriction in CSW—it worsens outcomes 1
  • Never use fluid restriction in subarachnoid hemorrhage patients at risk of vasospasm 1

Critical Correction Rate Guidelines

Standard Correction Limits

Maximum correction: 8 mEq/L in 24 hours for all patients 1, 2, 3

  • For severe symptoms: Correct 6 mEq/L over first 6 hours, then limit remaining correction to 2 mEq/L over next 18 hours 1
  • High-risk patients: 4-6 mEq/L per day maximum 1

Calculating Sodium Deficit

Formula: Desired increase in Na (mEq/L) × (0.5 × ideal body weight in kg) 1, 4


Management of Overcorrection

If sodium correction exceeds 8 mEq/L in 24 hours, act immediately to prevent osmotic demyelination syndrome. 1

Rescue Protocol

  • Discontinue current fluids immediately 1
  • Switch to D5W (5% dextrose in water) 1
  • Administer desmopressin (dDAVP) to slow or reverse rapid rise 1, 6
  • Goal: Relower sodium to bring total 24-hour correction to ≤8 mEq/L 1

Osmotic Demyelination Syndrome (ODS)

  • Occurs 2-7 days after overly rapid correction 1
  • Symptoms: Dysarthria, dysphagia, oculomotor dysfunction, quadriparesis, parkinsonism 1, 7
  • Risk: 0.5-1.5% in liver transplant recipients 1

Common Pitfalls to Avoid

  • Ignoring mild hyponatremia (130-135 mEq/L): Associated with increased falls (21% vs 5%), fractures, and mortality 1, 7
  • Using fluid restriction in CSW: Worsens outcomes, especially in subarachnoid hemorrhage 1
  • Correcting chronic hyponatremia too rapidly: Exceeding 8 mEq/L in 24 hours risks ODS 1, 7
  • Using hypertonic saline in hypervolemic hyponatremia without severe symptoms: Worsens edema and ascites 1
  • Inadequate monitoring during active correction: Check sodium every 2 hours for severe symptoms, every 4 hours for mild symptoms 1
  • Failing to distinguish SIADH from CSW in neurosurgical patients: They require opposite treatments 1
  • Using normal saline in SIADH: May worsen hyponatremia through dilution 1

Monitoring Protocol

Severe Symptomatic Patients

  • Serum sodium every 2 hours during initial correction 1
  • ICU admission for close monitoring 2

Mild Symptoms or Asymptomatic

  • Serum sodium every 4-6 hours initially 1, 4
  • Daily monitoring once stable 1

After Resolution of Severe Symptoms

  • Continue monitoring every 4 hours 1
  • Watch for signs of ODS for 7 days post-correction 1

References

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Hyponatremia in SIADH

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Oral Sodium Supplementation in Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.